Global Oncology Drug Market Research Report 2020
Table of Contents1 Oncology Drug Market Overview
1.1 Product Overview and Scope of Oncology Drug
1.2 Oncology Drug Segment by Type
1.2.1 Global Oncology Drug Sales Growth Rate Comparison by Type (2021-2026)
1.2.2 Chemotherapy
1.2.3 Targeted Therapy
1.2.4 Immunotherapy
1.2.5 Hormonal Therapy
1.2.6 Others
1.3 Oncology Drug Segment by Application
1.3.1 Oncology Drug Sales Comparison by Application: 2020 VS 2026
1.3.2 Blood Cancer
1.3.3 Breast Cancer
1.3.4 gastrointestinal Tract Cancer
1.3.5 Prostate Cancer
1.3.6 Lung Cancer
1.3.7 Skin Cancer
1.4 Global Oncology Drug Market Size Estimates and Forecasts
1.4.1 Global Oncology Drug Revenue 2015-2026
1.4.2 Global Oncology Drug Sales 2015-2026
1.4.3 Oncology Drug Market Size by Region: 2020 Versus 2026
2 Global Oncology Drug Market Competition by Manufacturers
2.1 Global Oncology Drug Sales Market Share by Manufacturers (2015-2020)
2.2 Global Oncology Drug Revenue Share by Manufacturers (2015-2020)
2.3 Global Oncology Drug Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Oncology Drug Manufacturing Sites, Area Served, Product Type
2.5 Oncology Drug Market Competitive Situation and Trends
2.5.1 Oncology Drug Market Concentration Rate
2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
2.7 Primary Interviews with Key Oncology Drug Players (Opinion Leaders)
3 Oncology Drug Retrospective Market Scenario by Region
3.1 Global Oncology Drug Retrospective Market Scenario in Sales by Region: 2015-2020
3.2 Global Oncology Drug Retrospective Market Scenario in Revenue by Region: 2015-2020
3.3 North America Oncology Drug Market Facts & Figures by Country
3.3.1 North America Oncology Drug Sales by Country
3.3.2 North America Oncology Drug Sales by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Oncology Drug Market Facts & Figures by Country
3.4.1 Europe Oncology Drug Sales by Country
3.4.2 Europe Oncology Drug Sales by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Oncology Drug Market Facts & Figures by Region
3.5.1 Asia Pacific Oncology Drug Sales by Region
3.5.2 Asia Pacific Oncology Drug Sales by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Oncology Drug Market Facts & Figures by Country
3.6.1 Latin America Oncology Drug Sales by Country
3.6.2 Latin America Oncology Drug Sales by Country
3.6.3 Mexico
3.6.3 Brazil
3.6.3 Argentina
3.7 Middle East and Africa Oncology Drug Market Facts & Figures by Country
3.7.1 Middle East and Africa Oncology Drug Sales by Country
3.7.2 Middle East and Africa Oncology Drug Sales by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Oncology Drug Historic Market Analysis by Type
4.1 Global Oncology Drug Sales Market Share by Type (2015-2020)
4.2 Global Oncology Drug Revenue Market Share by Type (2015-2020)
4.3 Global Oncology Drug Price Market Share by Type (2015-2020)
4.4 Global Oncology Drug Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Global Oncology Drug Historic Market Analysis by Application
5.1 Global Oncology Drug Sales Market Share by Application (2015-2020)
5.2 Global Oncology Drug Revenue Market Share by Application (2015-2020)
5.3 Global Oncology Drug Price by Application (2015-2020)
6 Company Profiles and Key Figures in Oncology Drug Business
6.1 Roche Ltd
6.1.1 Corporation Information
6.1.2 Roche Ltd Description, Business Overview and Total Revenue
6.1.3 Roche Ltd Oncology Drug Sales, Revenue and Gross Margin (2015-2020)
6.1.4 Roche Ltd Products Offered
6.1.5 Roche Ltd Recent Development
6.2 Novartis AG
6.2.1 Novartis AG Oncology Drug Production Sites and Area Served
6.2.2 Novartis AG Description, Business Overview and Total Revenue
6.2.3 Novartis AG Oncology Drug Sales, Revenue and Gross Margin (2015-2020)
6.2.4 Novartis AG Products Offered
6.2.5 Novartis AG Recent Development
6.3 Bristol-Myers Squibb
6.3.1 Bristol-Myers Squibb Oncology Drug Production Sites and Area Served
6.3.2 Bristol-Myers Squibb Description, Business Overview and Total Revenue
6.3.3 Bristol-Myers Squibb Oncology Drug Sales, Revenue and Gross Margin (2015-2020)
6.3.4 Bristol-Myers Squibb Products Offered
6.3.5 Bristol-Myers Squibb Recent Development
6.4 Celgene Corporation
6.4.1 Celgene Corporation Oncology Drug Production Sites and Area Served
6.4.2 Celgene Corporation Description, Business Overview and Total Revenue
6.4.3 Celgene Corporation Oncology Drug Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Celgene Corporation Products Offered
6.4.5 Celgene Corporation Recent Development
6.5 Johnson & Johnson
6.5.1 Johnson & Johnson Oncology Drug Production Sites and Area Served
6.5.2 Johnson & Johnson Description, Business Overview and Total Revenue
6.5.3 Johnson & Johnson Oncology Drug Sales, Revenue and Gross Margin (2015-2020)
6.5.4 Johnson & Johnson Products Offered
6.5.5 Johnson & Johnson Recent Development
6.6 Pfizer Inc.
6.6.1 Pfizer Inc. Oncology Drug Production Sites and Area Served
6.6.2 Pfizer Inc. Description, Business Overview and Total Revenue
6.6.3 Pfizer Inc. Oncology Drug Sales, Revenue and Gross Margin (2015-2020)
6.6.4 Pfizer Inc. Products Offered
6.6.5 Pfizer Inc. Recent Development
6.7 Astra Zenca Plc
6.6.1 Astra Zenca Plc Oncology Drug Production Sites and Area Served
6.6.2 Astra Zenca Plc Description, Business Overview and Total Revenue
6.6.3 Astra Zenca Plc Oncology Drug Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Astra Zenca Plc Products Offered
6.7.5 Astra Zenca Plc Recent Development
6.8 Eli Lilly And Company.
6.8.1 Eli Lilly And Company. Oncology Drug Production Sites and Area Served
6.8.2 Eli Lilly And Company. Description, Business Overview and Total Revenue
6.8.3 Eli Lilly And Company. Oncology Drug Sales, Revenue and Gross Margin (2015-2020)
6.8.4 Eli Lilly And Company. Products Offered
6.8.5 Eli Lilly And Company. Recent Development
6.9 Glaxosmithkline Plc
6.9.1 Glaxosmithkline Plc Oncology Drug Production Sites and Area Served
6.9.2 Glaxosmithkline Plc Description, Business Overview and Total Revenue
6.9.3 Glaxosmithkline Plc Oncology Drug Sales, Revenue and Gross Margin (2015-2020)
6.9.4 Glaxosmithkline Plc Products Offered
6.9.5 Glaxosmithkline Plc Recent Development
6.10 Merck & Co.
6.10.1 Merck & Co. Oncology Drug Production Sites and Area Served
6.10.2 Merck & Co. Description, Business Overview and Total Revenue
6.10.3 Merck & Co. Oncology Drug Sales, Revenue and Gross Margin (2015-2020)
6.10.4 Merck & Co. Products Offered
6.10.5 Merck & Co. Recent Development
6.11 Sanofi
6.11.1 Sanofi Oncology Drug Production Sites and Area Served
6.11.2 Sanofi Oncology Drug Description, Business Overview and Total Revenue
6.11.3 Sanofi Oncology Drug Sales, Revenue and Gross Margin (2015-2020)
6.11.4 Sanofi Products Offered
6.11.5 Sanofi Recent Development
6.12 Amgen Inc.
6.12.1 Amgen Inc. Oncology Drug Production Sites and Area Served
6.12.2 Amgen Inc. Oncology Drug Description, Business Overview and Total Revenue
6.12.3 Amgen Inc. Oncology Drug Sales, Revenue and Gross Margin (2015-2020)
6.12.4 Amgen Inc. Products Offered
6.12.5 Amgen Inc. Recent Development
6.13 Abbvie
6.13.1 Abbvie Oncology Drug Production Sites and Area Served
6.13.2 Abbvie Oncology Drug Description, Business Overview and Total Revenue
6.13.3 Abbvie Oncology Drug Sales, Revenue and Gross Margin (2015-2020)
6.13.4 Abbvie Products Offered
6.13.5 Abbvie Recent Development
7 Oncology Drug Manufacturing Cost Analysis
7.1 Oncology Drug Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price Trend
7.1.3 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Oncology Drug
7.4 Oncology Drug Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Oncology Drug Distributors List
8.3 Oncology Drug Customers
9 Market Dynamics
9.1 Market Trends
9.2 Opportunities and Drivers
9.3 Challenges
9.4 Porter's Five Forces Analysis
10 Global Market Forecast
10.1 Global Oncology Drug Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Oncology Drug by Type (2021-2026)
10.1.2 Global Forecasted Revenue of Oncology Drug by Type (2021-2026)
10.2 Oncology Drug Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Oncology Drug by Application (2021-2026)
10.2.2 Global Forecasted Revenue of Oncology Drug by Application (2021-2026)
10.3 Oncology Drug Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Oncology Drug by Region (2021-2026)
10.3.2 Global Forecasted Revenue of Oncology Drug by Region (2021-2026)
10.4 North America Oncology Drug Estimates and Projections (2021-2026)
10.5 Europe Oncology Drug Estimates and Projections (2021-2026)
10.6 Asia Pacific Oncology Drug Estimates and Projections (2021-2026)
10.7 Latin America Oncology Drug Estimates and Projections (2021-2026)
10.8 Middle East and Africa Oncology Drug Estimates and Projections (2021-2026)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of TablesTable 1. Global Oncology Drug Sales (K MT) Growth Rate Comparison by Type (2015-2026)
Table 2. Global Oncology Drug Sales (K MT) Comparison by Application: 2020 VS 2026
Table 3. Global Oncology Drug Market Size by Type (K MT) (US$ Million) (2020 VS 2026)
Table 4. Global Key Oncology Drug Manufacturers Covered in This Study
Table 5. Global Oncology Drug Sales (K MT) by Manufacturers (2015-2020)
Table 6. Global Oncology Drug Sales Share by Manufacturers (2015-2020)
Table 7. Global Oncology Drug Revenue (Million USD) by Manufacturers (2015-2020)
Table 8. Global Oncology Drug Revenue Share by Manufacturers (2015-2020)
Table 9. Global Market Oncology Drug Average Price (USD/MT) of Key Manufacturers (2015-2020)
Table 10. Manufacturers Oncology Drug Sales Sites and Area Served
Table 11. Manufacturers Oncology Drug Product Types
Table 12. Global Oncology Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Oncology Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Oncology Drug as of 2019)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Main Points Interviewed from Key Oncology Drug Players
Table 16. Global Oncology Drug Sales (K MT) by Region (2015-2020)
Table 17. Global Oncology Drug Sales Market Share by Region (2015-2020)
Table 18. Global Oncology Drug Revenue (Million US$) by Region (2015-2020)
Table 19. Global Oncology Drug Revenue Market Share by Region (2015-2020)
Table 20. North America Oncology Drug Sales by Country (2015-2020) (K MT)
Table 21. North America Oncology Drug Sales Market Share by Country (2015-2020)
Table 22. North America Oncology Drug Revenue by Country (2015-2020) (US$ Million)
Table 23. North America Oncology Drug Revenue Market Share by Country (2015-2020)
Table 24. Europe Oncology Drug Sales by Country (2015-2020) (K MT)
Table 25. Europe Oncology Drug Sales Market Share by Country (2015-2020)
Table 26. Europe Oncology Drug Revenue by Country (2015-2020) (US$ Million)
Table 27. Europe Oncology Drug Revenue Market Share by Country (2015-2020)
Table 28. Asia Pacific Oncology Drug Sales by Region (2015-2020) (K MT)
Table 29. Asia Pacific Oncology Drug Sales Market Share by Region (2015-2020)
Table 30. Asia Pacific Oncology Drug Revenue by Region (2015-2020) (US$ Million)
Table 31. Asia Pacific Oncology Drug Revenue Market Share by Region (2015-2020)
Table 32. Latin America Oncology Drug Sales by Country (2015-2020) (K MT)
Table 33. Latin America Oncology Drug Sales Market Share by Country (2015-2020)
Table 34. Latin America Oncology Drug Revenue by Country (2015-2020) (US$ Million)
Table 35. Latin America Oncology Drug Revenue Market Share by Country (2015-2020)
Table 36. Middle East and Africa Oncology Drug Sales by Country (2015-2020) (K MT)
Table 37. Middle East and Africa Oncology Drug Sales Market Share by Country (2015-2020)
Table 38. Middle East and Africa Oncology Drug Revenue by Country (2015-2020) (US$ Million)
Table 39. Middle East and Africa Oncology Drug Revenue Market Share by Country (2015-2020)
Table 40. Global Oncology Drug Sales (K MT) by Type (2015-2020)
Table 41. Global Oncology Drug Sales Share by Type (2015-2020)
Table 42. Global Oncology Drug Revenue (Million US$) by Type (2015-2020)
Table 43. Global Oncology Drug Revenue Share by Type (2015-2020)
Table 44. Global Oncology Drug Price (USD/MT) by Type (2015-2020)
Table 45. Global Oncology Drug Sales (K MT) by Application (2015-2020)
Table 46. Global Oncology Drug Sales Market Share by Application (2015-2020)
Table 47. Global Oncology Drug Sales Growth Rate by Application (2015-2020)
Table 48. Roche Ltd Oncology Drug Corporation Information
Table 49. Roche Ltd Description and Business Overview
Table 50. Roche Ltd Oncology Drug Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 51. Roche Ltd Main Product
Table 52. Roche Ltd Recent Development
Table 53. Novartis AG Oncology Drug Corporation Information
Table 54. Novartis AG Corporation Information
Table 55. Novartis AG Oncology Drug Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 56. Novartis AG Main Product
Table 57. Novartis AG Recent Development
Table 58. Bristol-Myers Squibb Oncology Drug Corporation Information
Table 59. Bristol-Myers Squibb Corporation Information
Table 60. Bristol-Myers Squibb Oncology Drug Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 61. Bristol-Myers Squibb Main Product
Table 62. Bristol-Myers Squibb Recent Development
Table 63. Celgene Corporation Oncology Drug Corporation Information
Table 64. Celgene Corporation Corporation Information
Table 65. Celgene Corporation Oncology Drug Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 66. Celgene Corporation Main Product
Table 67. Celgene Corporation Recent Development
Table 68. Johnson & Johnson Oncology Drug Corporation Information
Table 69. Johnson & Johnson Corporation Information
Table 70. Johnson & Johnson Oncology Drug Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 71. Johnson & Johnson Main Product
Table 72. Johnson & Johnson Recent Development
Table 73. Pfizer Inc. Oncology Drug Corporation Information
Table 74. Pfizer Inc. Corporation Information
Table 75. Pfizer Inc. Oncology Drug Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 76. Pfizer Inc. Main Product
Table 77. Pfizer Inc. Recent Development
Table 78. Astra Zenca Plc Oncology Drug Corporation Information
Table 79. Astra Zenca Plc Corporation Information
Table 80. Astra Zenca Plc Oncology Drug Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 81. Astra Zenca Plc Main Product
Table 82. Astra Zenca Plc Recent Development
Table 83. Eli Lilly And Company. Oncology Drug Corporation Information
Table 84. Eli Lilly And Company. Corporation Information
Table 85. Eli Lilly And Company. Oncology Drug Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 86. Eli Lilly And Company. Main Product
Table 87. Eli Lilly And Company. Recent Development
Table 88. Glaxosmithkline Plc Oncology Drug Corporation Information
Table 89. Glaxosmithkline Plc Corporation Information
Table 90. Glaxosmithkline Plc Oncology Drug Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 91. Glaxosmithkline Plc Main Product
Table 92. Glaxosmithkline Plc Recent Development
Table 93. Merck & Co. Oncology Drug Corporation Information
Table 94. Merck & Co. Corporation Information
Table 95. Merck & Co. Oncology Drug Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 96. Merck & Co. Main Product
Table 97. Merck & Co. Recent Development
Table 98. Sanofi Oncology Drug Corporation Information
Table 99. Sanofi Corporation Information
Table 100. Sanofi Oncology Drug Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 101. Sanofi Main Product
Table 102. Sanofi Recent Development
Table 103. Amgen Inc. Oncology Drug Corporation Information
Table 104. Amgen Inc. Corporation Information
Table 105. Amgen Inc. Oncology Drug Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 106. Amgen Inc. Main Product
Table 107. Amgen Inc. Recent Development
Table 108. Abbvie Oncology Drug Corporation Information
Table 109. Abbvie Corporation Information
Table 110. Abbvie Oncology Drug Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 111. Abbvie Main Product
Table 112. Abbvie Recent Development
Table 113. Sales Base and Market Concentration Rate of Raw Material
Table 114. Key Suppliers of Raw Materials
Table 115. Oncology Drug Distributors List
Table 116. Oncology Drug Customers List
Table 117. Market Key Trends
Table 118. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 119. Key Challenges
Table 120. Global Oncology Drug Sales (K MT) Forecast by Type (2021-2026)
Table 121. Global Oncology Drug Sales Market Share Forecast by Type (2021-2026)
Table 122. Global Oncology Drug Revenue (Million US$) Forecast by Type (2021-2026)
Table 123. Global Oncology Drug Revenue (Million US$) Market Share Forecast by Type (2021-2026)
Table 124. Global Oncology Drug Sales (K MT) Forecast by Application (2021-2026)
Table 125. Global Oncology Drug Revenue (Million US$) Forecast by Application (2021-2026)
Table 126. Global Oncology Drug Sales (K MT) Forecast by Region (2021-2026)
Table 127. Global Oncology Drug Sales Market Share Forecast by Region (2021-2026)
Table 128. Global Oncology Drug Revenue Forecast by Region (2021-2026) (US$ Million)
Table 129. Global Oncology Drug Revenue Market Share Forecast by Region (2021-2026)
Table 130. Research Programs/Design for This Report
Table 131. Key Data Information from Secondary Sources
Table 132. Key Data Information from Primary Sources
List of FiguresFigure 1. Picture of Oncology Drug
Figure 2. Global Oncology Drug Sales Market Share by Type: 2020 VS 2026
Figure 3. Chemotherapy Product Picture
Figure 4. Targeted Therapy Product Picture
Figure 5. Immunotherapy Product Picture
Figure 6. Hormonal Therapy Product Picture
Figure 7. Others Product Picture
Figure 8. Global Oncology Drug Consumption Market Share by Application: 2020 VS 2026
Figure 9. Blood Cancer
Figure 10. Breast Cancer
Figure 11. gastrointestinal Tract Cancer
Figure 12. Prostate Cancer
Figure 13. Lung Cancer
Figure 14. Skin Cancer
Figure 15. Global Oncology Drug Market Size 2015-2026 (US$ Million)
Figure 16. Global Oncology Drug Sales Capacity (K MT) (2015-2026)
Figure 17. Global Oncology Drug Market Size Market Share by Region: 2020 Versus 2026
Figure 18. Oncology Drug Sales Share by Manufacturers in 2020
Figure 19. Global Oncology Drug Revenue Share by Manufacturers in 2019
Figure 20. The Global 5 and 10 Largest Players: Market Share by Oncology Drug Revenue in 2019
Figure 21. Oncology Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 22. Global Oncology Drug Sales Market Share by Region (2015-2020)
Figure 23. Global Oncology Drug Sales Market Share by Region in 2019
Figure 24. Global Oncology Drug Revenue Market Share by Region (2015-2020)
Figure 25. Global Oncology Drug Revenue Market Share by Region in 2019
Figure 26. North America Oncology Drug Sales Market Share by Country in 2019
Figure 27. North America Oncology Drug Revenue Market Share by Country in 2019
Figure 28. U.S. Oncology Drug Sales Growth Rate (2015-2020) (K MT)
Figure 29. U.S. Oncology Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 30. Canada Oncology Drug Sales Growth Rate (2015-2020) (K MT)
Figure 31. Canada Oncology Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 32. Europe Oncology Drug Sales Market Share by Country in 2019
Figure 33. Europe Oncology Drug Revenue Market Share by Country in 2019
Figure 34. Germany Oncology Drug Sales Growth Rate (2015-2020) (K MT)
Figure 35. Germany Oncology Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. France Oncology Drug Sales Growth Rate (2015-2020) (K MT)
Figure 37. France Oncology Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. U.K. Oncology Drug Sales Growth Rate (2015-2020) (K MT)
Figure 39. U.K. Oncology Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. Italy Oncology Drug Sales Growth Rate (2015-2020) (K MT)
Figure 41. Italy Oncology Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 42. Russia Oncology Drug Sales Growth Rate (2015-2020) (K MT)
Figure 43. Russia Oncology Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 44. Asia Pacific Oncology Drug Sales Market Share by Region in 2019
Figure 45. Asia Pacific Oncology Drug Revenue Market Share by Region in 2019
Figure 46. China Oncology Drug Sales Growth Rate (2015-2020) (K MT)
Figure 47. China Oncology Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. Japan Oncology Drug Sales Growth Rate (2015-2020) (K MT)
Figure 49. Japan Oncology Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. South Korea Oncology Drug Sales Growth Rate (2015-2020) (K MT)
Figure 51. South Korea Oncology Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. India Oncology Drug Sales Growth Rate (2015-2020) (K MT)
Figure 53. India Oncology Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Australia Oncology Drug Sales Growth Rate (2015-2020) (K MT)
Figure 55. Australia Oncology Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Taiwan Oncology Drug Sales Growth Rate (2015-2020) (K MT)
Figure 57. Taiwan Oncology Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. Indonesia Oncology Drug Sales Growth Rate (2015-2020) (K MT)
Figure 59. Indonesia Oncology Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. Thailand Oncology Drug Sales Growth Rate (2015-2020) (K MT)
Figure 61. Thailand Oncology Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Malaysia Oncology Drug Sales Growth Rate (2015-2020) (K MT)
Figure 63. Malaysia Oncology Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. Philippines Oncology Drug Sales Growth Rate (2015-2020) (K MT)
Figure 65. Philippines Oncology Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. Vietnam Oncology Drug Sales Growth Rate (2015-2020) (K MT)
Figure 67. Vietnam Oncology Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Latin America Oncology Drug Sales Market Share by Country in 2019
Figure 69. Latin America Oncology Drug Revenue Market Share by Country in 2019
Figure 70. Mexico Oncology Drug Sales Growth Rate (2015-2020) (K MT)
Figure 71. Mexico Oncology Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Brazil Oncology Drug Sales Growth Rate (2015-2020) (K MT)
Figure 73. Brazil Oncology Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Argentina Oncology Drug Sales Growth Rate (2015-2020) (K MT)
Figure 75. Argentina Oncology Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Middle East and Africa Oncology Drug Sales Market Share by Country in 2019
Figure 77. Middle East and Africa Oncology Drug Revenue Market Share by Country in 2019
Figure 78. Turkey Oncology Drug Sales Growth Rate (2015-2020) (K MT)
Figure 79. Turkey Oncology Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Saudi Arabia Oncology Drug Sales Growth Rate (2015-2020) (K MT)
Figure 81. Saudi Arabia Oncology Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. U.A.E Oncology Drug Sales Growth Rate (2015-2020) (K MT)
Figure 83. U.A.E Oncology Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Sales Market Share of Oncology Drug by Type (2015-2020)
Figure 85. Sales Market Share of Oncology Drug by Type in 2019
Figure 86. Revenue Share of Oncology Drug by Type (2015-2020)
Figure 87. Revenue Market Share of Oncology Drug by Type in 2019
Figure 88. Global Oncology Drug Sales Growth by Type (2015-2020) (K MT)
Figure 89. Global Oncology Drug Sales Market Share by Application (2015-2020)
Figure 90. Global Oncology Drug Sales Market Share by Application in 2019
Figure 91. Global Revenue Share of Oncology Drug by Application (2015-2020)
Figure 92. Global Revenue Share of Oncology Drug by Application in 2020
Figure 93. Roche Ltd Total Revenue (US$ Million): 2019 Compared with 2018
Figure 94. Novartis AG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 95. Bristol-Myers Squibb Total Revenue (US$ Million): 2019 Compared with 2018
Figure 96. Celgene Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 97. Johnson & Johnson Total Revenue (US$ Million): 2019 Compared with 2018
Figure 98. Pfizer Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 99. Astra Zenca Plc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 100. Eli Lilly And Company. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 101. Glaxosmithkline Plc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 102. Merck & Co. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 103. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 104. Amgen Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 105. Abbvie Total Revenue (US$ Million): 2019 Compared with 2018
Figure 106. Price Trend of Key Raw Materials
Figure 107. Manufacturing Cost Structure of Oncology Drug
Figure 108. Manufacturing Process Analysis of Oncology Drug
Figure 109. Oncology Drug Industrial Chain Analysis
Figure 110. Channels of Distribution
Figure 111. Distributors Profiles
Figure 112. Porter's Five Forces Analysis
Figure 113. North America Oncology Drug Sales (K MT) and Growth Rate Forecast (2021-2026)
Figure 114. North America Oncology Drug Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 115. Europe Oncology Drug Sales (K MT) and Growth Rate Forecast (2021-2026)
Figure 116. Europe Oncology Drug Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 117. Latin America Oncology Drug Sales (K MT) and Growth Rate Forecast (2021-2026)
Figure 118. Latin America Oncology Drug Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 119. Middle East and Africa Oncology Drug Sales (K MT) and Growth Rate Forecast (2021-2026)
Figure 120. Middle East and Africa Oncology Drug Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 121. Asia Pacific Oncology Drug Sales (K MT) and Growth Rate Forecast (2021-2026)
Figure 122. Asia Pacific Oncology Drug Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 123. Bottom-up and Top-down Approaches for This Report
Figure 124. Data Triangulation
Figure 125. Key Executives Interviewed